Upcoming Important Deadlines

2025 Call for Abstracts

Submittal deadline has passed


Late-breaking Abstracts

Opens September 2, 2025

Submittal deadline September 30, 2025


Login and submissions support
Email: sabcs@support.ctimeetingtech.com 
Telephone: +1 217-398-1792.

Abstracts

Late-breaking abstracts can be submitted now

The San Antonio Breast Cancer Symposium will accept late-breaking abstracts through Tuesday, September 30.

Categories for late-breaking abstracts:

  1. Adverse Effects of Cancer Treatment and Symptom Management
  2. Animal and ex vivo Models 
  3. Artificial Intelligence, Computational Biology, and Systems Biology 
  4. Behavioral and Population Science 
  5. Breast Cancer Risk, Genetics, and Prevention 
  6. Breast Cancer: Early Stage - HER2+ 
  7. Breast Cancer: Early Stage - Hormone Receptor Positive 
  8. Breast Cancer: Early Stage - Other 
  9. Breast Cancer: Early Stage - Triple Negative 
  10. Breast Cancer: Metastatic - HER2+ 
  11.  Breast Cancer: Metastatic - Hormone Receptor Positive 
  12. Breast Cancer: Metastatic - Other 
  13. Breast Cancer: Metastatic - Triple Negative 
  14. Cancer Health Disparities 
  15. Cancer Survivorship and Quality of Life 
  16. Clinical Biomarkers, Translational Research, and Precision Medicine 
  17. Drug Discovery, Design, and Delivery 
  18. Experimental Therapeutics and Early Phase Trials 
  19. Imaging / Early Detection 
  20. Mechanisms of Resistance 
  21. Molecular and Cell Tumor Biology 
  22. Pathology
  23. Policy, Access to Care, Health Outcomes and Cancer Care Delivery 
  24. Radiation Oncology 
  25. Real-World Data and Real-World Evidence
  26. Surgery 
  27. Tumor Microenvironment, Immunology, and Angiogenesis

Submit your late-breaking abstract

Note: If you experience issues logging in, or have questions about the submission system, email sabcs@support.ctimeetingtech.com, or call +1 217-398-1792.


Spring abstract submission decisions coming this month 

SABCS abstract committee members have met and are making their final decision on presentations and posters for SABCS 2025. The first author of each abstract will be sent an email if their abstract is chosen.

Remember:

  • Decision letters will be sent by mid-September. 
  • Financial disclosures will be required upon acceptance.
  • Upon acceptance, the presenting author will receive presentation guidelines, submission links and a detailed timeline of deadlines.

For answers to frequently asked questions, read our Abstract Guidelines (PDF)

Review Your Abstract Submission

Note: If you experience issues logging in, or have questions about the submission system, email sabcs@support.ctimeetingtech.com, or call +1 217-398-1792.


SABCS 2024 proceedings

The full proceedings of SABCS 2024 were published as a supplement to the June issue of Clinical Cancer Research, available from the American Association for Cancer Research. You can read all of the 2024 abstracts in the supplement online at Volume 31 Issue 12_Supplement | Clinical Cancer Research | American Association for Cancer Research


Confirmation of No Prior Publication/Presentation

Authors who submit an abstract confirm they have not previously published these data, they have not previously presented them at another scientific meeting, and that they are not planning to present or publish them prior to the dates of the SABCS® 2025. Preprints (draft research papers posted online before peer review) are not considered to be a prior publication if they are posted online before abstracts are submitted SABCS®. 

Abstracts submitted to SABCS® are confidential and embargoed until SABCS® publishes the abstracts.

Certain laws may require disclosure of clinical trial data through federal and international registries within a specific amount of time following trial completion, or disclosure of clinical trial data by federal and international agencies for regulatory purposes related to drug safety and efficacy. Such disclosures will not be considered a violation of the SABCS’s Embargo Policy, but the courtesy of advance notice to the SABCS® by email at sabcs@uthscsa.edu is requested.   

Any other exceptions to this policy are at the discretion of SABCS® leadership.


Copyright

All accepted abstracts, other than those that are withdrawn prior to publication and any that may have been accepted as a special late exception, will be published in the online Symposium proceedings, as an online only supplement in Clinical Cancer Research, and as SABCS Sessions and Poster Resources on the SABCS website. In addition, San Antonio Breast Cancer Symposium currently contracts with other parties to record and transcribe oral presentations for online slide review and streaming on the SABCS website. All of these resources are made available to the user at no charge.

Read the full copyright rules and standards